VolitionRx Limited (VNRX)

VolitionRx Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	-23.5	-27.26	-35.68
Depreciation & Amortization	0.98	1.11	1.15
Stock-Based Compensation	1.74	1.27	2.29
Other Adjustments	1.98	0.23	0.04
Change in Receivables	-0.21	0.13	-0.17
Changes in Accounts Payable	0.08	-1.22	1.22
Changes in Accrued Expenses	0.05	-	-0.01
Changes in Unearned Revenue	-0.6	-0.11	13
Changes in Other Operating Activities	-0.21	-0.06	0.09
Operating Cash Flow	-19.68	-25.89	-18.06
Capital Expenditures	-0.09	-0.28	-1.08
Purchases of Intangible Assets	-	-0.3	-
Investing Cash Flow	-0.09	-0.57	-1.08
Long-Term Debt Issued	7.89	1.37	1.88
Long-Term Debt Repaid	-1.76	-1.16	-1.05
Net Long-Term Debt Issued (Repaid)	6.13	0.21	0.83
Issuance of Common Stock	11.17	8.59	28.39
Repurchase of Common Stock	-0.21	-0.14	-0.24
Net Common Stock Issued (Repurchased)	10.96	8.45	28.15
Financing Cash Flow	17.09	8.66	28.98
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.53	0.34	0.03
Net Cash Flow	-2.15	-17.47	9.86
Free Cash Flow	-19.77	-26.17	-19.15
FCF Margin	-1144.67%	-2121.68%	-2469.59%
Free Cash Flow Per Share	-0.19	-0.30	-0.27
Levered Free Cash Flow	-17.01	-27.31	-20.11
Unlevered Free Cash Flow	-21.52	-27.57	-21.61

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q